ESC 365 - Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction

Open Access

Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction

Session: Medical therapy in the context of acute heart failure

Topic: Pharmacotherapy

Speaker: Mrs S. Valdivielso (Barcelona, ES)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Mrs Sandra Valdivielso

Hospital del Mar, Barcelona (Spain)

0 follower

6 more presentations in this session

Changes in medicines use before and after hospitalisation for heart failure: Australian nationwide cohort study

Speaker: Doctor H. Raaket (Sydney, AU)

Relationship between left ventricular reverse remodeling and guideline-directed medical therapy intensity in de novo heart failure with reduced ejection fraction patients: insight from TRANS-HF trial

Speaker: Doctor C. Lee (Seoul, KR)

Impact of worsening heart failure events and renal impairment on vericiguat drug use patterns in real-world care

Speaker: Doctor F. Kerwagen (Wuerzburg, DE)

Discharge medical treatment implementation in patients admitted for AHF: preliminary data from the BRING-UP3 HF study

Speaker: Doctor M. Gori (Bergamo, IT)

Pre-discharge versus post-discharge initiation of quadruple medical therapy in acute heart failure with reduced ejection fraction: Insights from the MCR-HF Registry

Speaker: Mr N. Phan (Ho Chi Minh, VN)

Access the full session

Medical therapy in the context of acute heart failure

Speakers: Mrs S. Valdivielso, Doctor H. Raaket, Doctor C. Lee, Doctor F. Kerwagen, Doctor M. Gori...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources